Pacira BioSciences' Change in Account Payables fell 198587.13% to -$12.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.0 million, marking a year-over-year decrease of 22811.3%. This contributed to the annual value of $3.1 million for FY2024, which is 23668.12% up from last year.
According to the latest figures from Q3 2025, Pacira BioSciences' Change in Account Payables is -$12.0 million, which was down 198587.13% from $6.9 million recorded in Q2 2025.
In the past 5 years, Pacira BioSciences' Change in Account Payables ranged from a high of $9.7 million in Q2 2024 and a low of -$12.0 million during Q3 2025
In the last 5 years, Pacira BioSciences' Change in Account Payables had a median value of -$325000.0 in 2024 and averaged -$139947.4.
Its Change in Account Payables has fluctuated over the past 5 years, first skyrocketed by 93293.98% in 2023, then crashed by 198587.13% in 2025.
Quarter analysis of 5 years shows Pacira BioSciences' Change in Account Payables stood at -$9.4 million in 2021, then skyrocketed by 116.86% to $1.6 million in 2022, then crashed by 167.38% to -$1.1 million in 2023, then skyrocketed by 69.68% to -$325000.0 in 2024, then tumbled by 3596.31% to -$12.0 million in 2025.
Its Change in Account Payables stands at -$12.0 million for Q3 2025, versus $6.9 million for Q2 2025 and $2.5 million for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value